perifosine

Drug Overview

Perifosine is an investigational oral medication that represents a specialized approach to treating various types of cancer. It is classified as a Targeted Therapy because it focuses on blocking specific signals inside a cell that tell it to grow and survive. Unlike traditional chemotherapy, which often kills all fast-growing cells, perifosine is designed to be a “Smart Drug” that interrupts the internal machinery of a tumor.

While it has been studied extensively in blood cancers and solid tumors, it remains an experimental agent. It is often tested in combination with other anti-cancer drugs to increase their effectiveness.

• Generic Name: Perifosine
• US Brand Names: None (Currently an investigational drug)
• Drug Class: Alkylphosphocholine; Akt Inhibitor (Targeted Therapy)
• Route of Administration: Oral (Capsule or tablet taken by mouth)
• FDA Approval Status: Not FDA Approved (Available only through clinical trials)
  
  Get insights on perifosine and its targeted therapy potential. Our expert medical facility delivers highly specialized oncology care and support.

What Is It and How Does It Work? (Mechanism of Action)

Perifosine works by disrupting the “command center” of a cancer cell. To understand how it works at the molecular level, we must look at a specific signaling pathway called the PI3K/Akt/mTOR pathway.

• Targeting the Akt Protein: In many cancers, a protein called Akt (also known as Protein Kinase B) is overactive. Think of Akt as a “green light” signal. When it is turned on, it tells the cancer cell to grow, multiply, and ignore the body’s natural signals to die.
• The Molecular Blockade: Perifosine is a synthetic fatty acid-like molecule. It works by preventing the Akt protein from moving to the cell membrane. If Akt cannot reach the membrane, it cannot be activated.
• Shutting Down the Pathway: By “unplugging” Akt, perifosine effectively turns the green light into a red light. This stops the signaling to other downstream proteins like mTOR.
• Inducing Apoptosis: Once the growth signal is cut off, the cancer cell loses its ability to survive. This leads to apoptosis, which is a process where the cell essentially self-destructs.
• Sensitization: Perifosine also makes the cell membrane more permeable, which may help other chemotherapy drugs enter the cancer cell more easily.

FDA Approved Clinical Indications

As of early 2026, perifosine has not received full FDA approval for any specific disease. It is strictly used in research settings for specific groups of patients.

Oncological Uses (Investigational):

• Multiple Myeloma: Studied in combination with other drugs like bortezomib or dexamethasone.
• Colorectal Cancer: Researching its effect on advanced or metastatic tumors.
• Waldenström Macroglobulinemia: A rare type of blood cancer.
• Neuroblastoma: Investigated in pediatric oncology.

Non-oncological Uses:

• None.

Dosage and Administration Protocols

In clinical trials, perifosine is taken daily. The dose is carefully managed by the research team to balance effectiveness with safety.

• 
  Dose Adjustments: Physicians monitor kidney and liver function closely. If a patient shows signs of renal (kidney) or hepatic (liver) insufficiency, the dose may be reduced or the treatment cycle may be paused.

Clinical Efficacy and Research Results

Clinical data from 2020–2025 has provided a clearer picture of where perifosine might be most useful.

• Multiple Myeloma Success: In Phase 2 trials, perifosine showed a “Disease Control Rate” (the percentage of patients whose cancer shrank or stayed stable) of approximately 40% to 60% when combined with standard treatments.
• Survival Data: Numerical data from earlier Phase 3 trials (such as the X-PECT trial) showed that while perifosine improved “Progression-Free Survival” (the time a patient lives without the cancer growing) in some groups, it did not always significantly improve the “Overall Survival” for the entire group of patients.
• Current Focus: Recent research is focusing on using perifosine as a “sensitizer”—a drug that makes other chemotherapies work better in patients who have become resistant to standard care.

Safety Profile and Side Effects

Perifosine is generally better tolerated than many high-dose chemotherapies, but it has a specific set of side effects that require medical management.

Black Box Warning:

• There is no official Black Box Warning for perifosine, as it is not yet an approved commercial product.

Common Side Effects (>10%)

• Gastrointestinal Issues: Nausea, vomiting, and diarrhea are the most frequent complaints.
• Fatigue: A general feeling of tiredness or weakness.
• Loss of Appetite: Reduced interest in eating, sometimes leading to weight loss.

Serious Adverse Events

• Renal Stress: Potential changes in kidney function tests (elevated creatinine).
• Bone Marrow Suppression: A drop in white blood cells or platelets, increasing the risk of infection or bruising.
• Hand-Foot Syndrome: Redness, swelling, or pain on the palms of the hands and soles of the feet.

Management Strategies

• For Nausea: Anti-nausea medications (antiemetics) are often prescribed to be taken before the perifosine dose.
• Hydration: Drinking plenty of fluids is essential to protect the kidneys during treatment.

Research Areas

In the fields of Immunotherapy and regenerative medicine, researchers are exploring how perifosine affects the “bone marrow niche.” While it is not a stem cell therapy itself, scientists are looking at how perifosine can change the environment where blood cells are made. Current research is investigating if perifosine can be used to “prime” the bone marrow so that newly transplanted stem cells or engineered immune cells (like CAR-T cells) can better regenerate and find cancer targets.

Patient Management and Practical Recommendations

Pre-treatment Tests to be Performed

• Baseline Blood Panel: A Complete Blood Count (CBC) to check white and red blood cell levels.
• Kidney and Liver Tests: To ensure your organs are healthy enough to process the medication.
• Imaging (CT/MRI): To measure the size of the tumor before starting the trial.

Precautions During Treatment

• Take with Food: Taking perifosine with a meal significantly reduces the chance of an upset stomach.
• Pregnancy: Perifosine can harm a developing fetus. Highly effective birth control is mandatory for both men and women during the trial.

“Do’s and Don’ts” List

• DO take the medication at the same time every day to keep levels steady in your blood.
• DO report any persistent diarrhea or vomiting to your trial nurse immediately.
• DON’T take any new herbal supplements or vitamins without asking your oncology team first.
• DON’T skip doses; if you miss a dose, follow the specific instructions provided by your clinical trial team.

Legal Disclaimer

The information provided in this guide is for educational and informational purposes only and does not substitute for professional medical advice, diagnosis, or treatment. Perifosine is an investigational drug and is not available for use outside of clinical trials. Always consult with your oncologist or a qualified healthcare provider regarding your specific medical condition and treatment options.